怀化高级足月胎儿模型(男婴、女婴任选)(西宁腹膜模型（矢状切面）) (今日更新中)

LA JOLLA, Calif. (KGTV) - A researcher at UC San Diego just got a million grant to further his work into nanosponge therapy.Liangfang Zhang, a professor of nanoengineering and bioengineering, has been working on creating macrophage cellular nanosponges, tiny particles covered in white blood cell membranes, to treat sepsis and other diseases."They can be used to bind to the virus and neutralize the virus," Zhang says. "So now the virus would lose the ability to infect the host cells."The nanosponges act as decoys, tricking a disease or virus into binding with them instead of with human cells. While the initial aim is to treat sepsis, Zhang says it has applications to other deadly diseases, including COVID-19."The formulation that we're developing for treatment of Sepsis is the same formulation that you will use with COVID-19," he says.The grant comes from CARB-X, a Boston-based medical philanthropy that specializes in funding research into antibacterial treatments. Zhang says the money will be used for his company, Cellics Therapeutics, to further advance the research into clinical trials, FDA approval, and production of the nanosponge therapy.Steve Chen, president and chief medical officer of Cellics Therapeutics, says he's hopeful they can advance the nanosponges into human trials within two years."We're essentially looking at how this platform can treat not just infectious disease or future pandemics, but you could actually have a lot of applications in any type of autoimmune diseases or any type of inflammatory diseases," says Chen.In an early study published this year, Zhang's research showed the nanosponges were around 90% effective at blocking infections from taking hold.RELATED: UC San Diego researchers testing nanosponges to fight COVID-19Chen says the research and trial period may take too long for the nanosponges to be used during the current coronavirus pandemic. But he's hopeful it will help make the next outbreak less severe."My sincere desire is that we are not going to need this for COVID-19. But I think this does position us very well for any potential future kind of viral outbreak," says Chen.Cellics is also working on a Red Blood Cell version of their nanosponges, which may be ready for human trials within a year. 2283

John McCain was admired by supporters and adversaries for his bravery as a military warrior and his courage to rise above party politics.He died Saturday at age 81.Here are some of the late senator's more memorable comments: 232

KANSAS CITY, Mo. - The numbers are in: more Americans will travel this Thanksgiving than the past 12. The travel organization AAA released its annual holiday travel forecast Thursday. It predicts nearly 51 million Americans will travel at least 50 miles to celebrate the holiday. That's a 3 percent increase from last year, and the highest number since 2005. Travelers can expect to pay more for gasoline than years past, but less for airfare. AAA expects 89 percent of travelers to get to their destination by driving. To avoid getting caught in traffic, experts say you should stay off the roads the Tuesday and Wednesday before Thanksgiving, especially in the afternoons. That's when normal workweek commuters and travelers are on the road at the same time. "Plan ahead. Try to make sure you're getting out the door early in the morning, if possible. If you can travel on the holiday, that would be even better for travelers," explained Tamara Johnson with AAA.Travel experts said the high number of travelers is a good indicator people are earning money and feel comfortable spending it. "A strong economy and labor market are generating rising incomes and higher consumer confidence, fueling a strong year for the travel industry, which will continue into the holiday season," said Bill Sutherland, AAA senior vice president of Travel and Publishing, in a press release.These are the top 10 Thanksgiving travel destinations, according to AAA.    1    Orlando, Florida 1535

KANSAS CITY, Mo. — There is no rule book when it comes to COVID-19, with endless questions still surrounding the potentially deadly virus. One big question that many are now asking: If you've already had the virus, should you get the vaccine when it becomes available? "Certainly right now, it's looking like they are going to recommend people that have had COVID to go ahead and get the vaccine when it's available to them, based either on their job or on their other health conditions," said Dr. Sarah Boyd, infectious diseases physician at Saint Luke's Health System.Boyd said it is important for everyone to get the vaccine, even those who already have had COVID-19."We know the majority of people that are at about 90 days, but there are some that probably longer," Boyd said. "Over the next few months, there will be information I am sure coming out about the natural course of immunity and if at some point you are at risk to get reinfection."Amanda Finley tested positive for the coronavirus twice and wants to get the vaccine as soon as she can."For me, I haven't had adverse reactions before, but the only way to know if it is going to affect long-haulers is if we try it," Finley said. "I just don't feel right saying, 'oh, somebody goes try it for me.' I will gladly do it. I will be first in line."She runs a Facebook group for COVID long-haulers.Some of the members in the group are excited about the vaccine, while others are nervous about it. But Finley said a big reason why she will get the virus is a simple one."Because I definitely do not want to get this again," Finley said. "It affects every system in the body. It's not just a respiratory disease, that is just how we found it. It affects your cardiovascular system, it affects your brain, it affects your muscles. Everything."The FDA will consider an emergency use authorization for the Pfizer vaccine this week.This story was first reported by Jordan Betts at KSHB in Kansas City, Missouri. 1975

LA JOLLA, Calif. (KGTV) -- A San Diego couple who met at a Japanese internment camp during World War II, has died this month. The wife succumbed to effects from the coronavirus.To Garrett Yamada, Elizabeth and Joseph were just mom and dad. "My dad loved fish 'n chips and spam, and my mom was into sushi and fine dining," Yamada laughed. But on May 11, Joseph Yamada died after a long battle with dementia. Nine days later, COVID-19 took Elizabeth. They were both 90 years old. "I miss them, but I'm proud of the life they lived," Yamada said. Through struggle and strife, the Yamadas became a prominent San Diego couple. Joseph was a world-renowned landscape architect whose projects included designs for Sea World, UC San Diego, and the Chula Vista Olympic Training Center. Elizabeth was an English teacher who later became a partner at her husband's firm. "They were a wonderful team together," Yamada said.But their love story began behind bars at Poston Japanese Internment Camp in Arizona. Last May, Elizabeth Kikuchi-Yamada shared her story with 10News about her move to the camp as a 12-year-old girl. During her time there, she wrote letters to respected San Diego city librarian, Clara Breed.Breed fought racial injustice by sending books, trinkets, and hope to children locked up in camp. "Clara cared about helping young people know that there was freedom beyond imprisonment. Freedom of the mind to grow. Freedom of the heart to deepen," Elizabeth Yamada said in 2019. It was a story she shared for decades until the virus suddenly took over. "The tragedy with COVID is it separates you physically," her son said. "But her mind was sharp until the very end."The Yamada's were born two days apart in 1930 and died nine days apart in 2020. They were a loving couple, inseparable, both in life and death. "It was God's timing that they go close together," Garrett Yamada said. Unfortunately, the Yamada family says they will not have a service due to COVID-19 restrictions on gatherings. 2006

来源：资阳报